This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velin, D.
Right arrow Articles by Acha-Orbea, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velin, D.
Right arrow Articles by Acha-Orbea, H.

 Previous Article  |  Next Article 

Journal of Virology, February 1999, p. 1729-1733, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Systemic Antibodies Can Inhibit Mouse Mammary Tumor Virus-Driven Superantigen Response in Mucosa-Associated Lymphoid Tissues

Dominique Velin,1,2,dagger Grigorios Fotopoulos,1,2 Jean-Pierre Kraehenbuhl,1,2,* and Hans Acha-Orbea2,3

Swiss Institute for Cancer Research1 and Institute for Biochemistry,2 University of Lausanne, and Ludwig Institute for Cancer Research, Lausanne Branch,3 1066 Epalinges, Switzerland

Received 6 April 1998/Accepted 27 October 1998

Many mucosal pathogens invade the host by initially infecting the organized mucosa-associated lymphoid tissue (o-MALT) such as Peyer's patches or nasal cavity-associated lymphoid tissue (NALT) before spreading systemically. There is no clear demonstration that serum antibodies can prevent infections in o-MALT. We have tested this possibility by using the mouse mammary tumor virus (MMTV) as a model system. In peripheral lymph nodes or in Peyer's patches or NALT, MMTV initially infects B lymphocytes, which as a consequence express a superantigen (SAg) activity. The SAg molecule induces the local activation of a subset of T cells within 6 days after MMTV infection. We report that similar levels of anti-SAg antibody (immunoglobulin G) in serum were potent inhibitors of the SAg-induced T-cell response both in peripheral lymph nodes and in Peyer's patches or NALT. This result clearly demonstrates that systemic antibodies can gain access to Peyer's patches or NALT.


* Corresponding author. Mailing address: Swiss Institute for Experimental Cancer Research, Ch-1066 Epalinges, Switzerland. Phone: (41 21) 692 58 56. Fax: (41 21) 652 69 33. E-mail: Jean-Pierre.Kraehenbuhl{at}isrec.unil.ch.

dagger Present address: Centre d'Immunologie Pierre Fabre, 74164 Saint-Julien en Genevois Cedex, France.


Journal of Virology, February 1999, p. 1729-1733, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Mpandi, M., Otten, L. A., Lavanchy, C., Acha-Orbea, H., Finke, D. (2003). Passive Immunization with Neutralizing Antibodies Interrupts the Mouse Mammary Tumor Virus Life Cycle. J. Virol. 77: 9369-9377 [Abstract] [Full Text]  
  • Shupp, J. W., Jett, M., Pontzer, C. H. (2002). Identification of a Transcytosis Epitope on Staphylococcal Enterotoxins. Infect. Immun. 70: 2178-2186 [Abstract] [Full Text]